文献速递烧伤创面修复

生物打印与实验室培养皮肤替代物在烧伤救治中的伦理挑战

Ethical Challenges of Bioprinted and Lab-Grown Skin Substitutes in Burn Care.
PubMed 文献 · J Burn Care Res · 2026-07-22

研究识别出生物打印与实验室培养皮肤替代物在烧伤救治中的五大伦理领域:所有权与本体论地位模糊、知情同意不足、知识产权复杂、分配不公及实证伦理研究缺乏。作者认为伦理与监管框架滞后,需在患者参与下解决所有权、同意、商业化和公平问题。

要点

  • 生物打印皮肤替代物面临所有权与杂合组织本体论地位模糊的伦理问题。
  • 现有知情同意流程不足以覆盖患者来源细胞的商业化和下游使用。
  • 高成本与全球资源差距导致分配不公,且缺乏烧伤患者参与的实证伦理研究。

核心结论

  • 生物打印与实验室培养皮肤替代物可能变革烧伤重建,但当前伦理与监管框架滞后。
  • 负责任地整合这些技术需解决所有权、同意、商业化和公平问题,并开展扎实的实证患者参与研究。

研究设计与样本

  • 叙述性综述,检索PubMed、Embase、Web of Science和Google Scholar(2010-2025),补充基础法律与生命伦理学文献。

主要发现

  • 识别出五个主要伦理领域:杂合生物打印组织的所有权与本体论地位模糊。
  • 知情同意流程不足以应对患者来源细胞的商业化和下游使用。
  • 复杂的知识产权环境可能限制获取和临床创新。
  • 高成本和全球资源差距驱动分配不公。
  • 几乎缺乏涉及烧伤患者或照护团队的实证伦理研究。

临床怎么用

  • 在临床转化中需关注生物打印皮肤替代物的所有权归属和患者来源细胞的商业化使用。
  • 知情同意应扩展至覆盖细胞商业化和下游研究用途。
  • 需考虑知识产权和成本对技术可及性的影响,促进公平分配。

局限性

  • 为叙述性综述,非系统评价,可能存在选择偏倚。
  • 纳入文献以概念和政策相关性为标准,缺乏定量合并分析。
  • 实证伦理研究几乎缺失,限制了对烧伤患者和照护团队实际观点的了解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe burns continue to impose significant global morbidity and mortality, particularly where surgical and critical-care resources are limited. As survival has improved, attention has shifted toward optimizing reconstruction. Bioprinted and lab-grown skin substitutes-building on advances in tissue engineering, cellular scaffolds, and 3D bioprinting-offer new possibilities for coverage, yet raise ethical, legal, and distributive challenges that remain underexamined in burn care. A narrative review was conducted using PubMed, Embase, Web of Science, and Google Scholar (2010-2025), supplemented by foundational legal and bioethics literature. Sources were selected for conceptual and policy relevance to ownership, consent, commercialization, intellectual property, and equity in regenerative skin technologies. Fifty publications spanning burn surgery, biobanking, organoid governance, IP law, and global health were synthesized inductively. Five major ethical domains emerged: (1) ambiguous ownership and ontological status of hybrid bioprinted tissues; (2) inadequacy of consent processes to address commercialization and downstream uses of patient-derived cells; (3) complex intellectual property environments that may restrict access and clinical innovation; (4) distributive injustice driven by high costs and global resource disparities; and (5) a near absence of empirical ethics research involving burn patients or care teams. Bioprinted and lab-grown skin substitutes could transform burn reconstruction, but current ethical and regulatory frameworks lag behind. Addressing ownership, consent, commercialization, and equity-supported by robust empirical engagement with patients-is essential for responsible integration of these technologies into burn care.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Khorsandi J, Mansoury B, Ahmed AB, et al. Ethical Challenges of Bioprinted and Lab-Grown Skin Substitutes in Burn Care. J Burn Care Res. 2026. PMID: 42485445. doi:10.1093/jbcr/irag125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。